BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33710456)

  • 21.
    Nicastro N; Rodriguez PV; Malpetti M; Bevan-Jones WR; Simon Jones P; Passamonti L; Aigbirhio FI; O'Brien JT; Rowe JB
    J Neurol; 2020 Feb; 267(2):341-349. PubMed ID: 31641878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracortical diffusion tensor imaging signature of microstructural changes in frontotemporal lobar degeneration.
    Torso M; Ridgway GR; Jenkinson M; Chance S;
    Alzheimers Res Ther; 2021 Oct; 13(1):180. PubMed ID: 34686217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffusion tensor analysis of corpus callosum in progressive supranuclear palsy.
    Ito S; Makino T; Shirai W; Hattori T
    Neuroradiology; 2008 Nov; 50(11):981-5. PubMed ID: 18779957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and neuroimaging characteristics of primary lateral sclerosis with overlapping features of progressive supranuclear palsy.
    Badihian N; Gatto RG; Satoh R; Ali F; Clark HM; Pham NTT; Whitwell JL; Josephs KA
    Eur J Neurol; 2024 Apr; ():e16320. PubMed ID: 38686979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo evaluation of white matter pathology in patients of progressive supranuclear palsy using TBSS.
    Saini J; Bagepally BS; Sandhya M; Pasha SA; Yadav R; Pal PK
    Neuroradiology; 2012 Jul; 54(7):771-80. PubMed ID: 22160214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration.
    Illán-Gala I; Nigro S; VandeVrede L; Falgàs N; Heuer HW; Painous C; Compta Y; Martí MJ; Montal V; Pagonabarraga J; Kulisevsky J; Lleó A; Fortea J; Logroscino G; Quattrone A; Quattrone A; Perry DC; Gorno-Tempini ML; Rosen HJ; Grinberg LT; Spina S; La Joie R; Rabinovici GD; Miller BL; Rojas JC; Seeley WW; Boxer AL
    JAMA Netw Open; 2022 Apr; 5(4):e229588. PubMed ID: 35486397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffusion Tensor MRI to Distinguish Progressive Supranuclear Palsy from α-Synucleinopathies.
    Spotorno N; Hall S; Irwin DJ; Rumetshofer T; Acosta-Cabronero J; Deik AF; Spindler MA; Lee EB; Trojanowski JQ; van Westen D; Nilsson M; Grossman M; Nestor PJ; McMillan CT; Hansson O
    Radiology; 2019 Dec; 293(3):646-653. PubMed ID: 31617796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic Susceptibility in Progressive Supranuclear Palsy Variants, Parkinson's Disease, and Corticobasal Syndrome.
    Satoh R; Weigand SD; Pham NTT; Ali F; Arani A; Senjem ML; Jack CR; Whitwell JL; Josephs KA
    Mov Disord; 2023 Dec; 38(12):2282-2290. PubMed ID: 37772771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multimodal neuroimaging relationships in progressive supranuclear palsy.
    Sintini I; Schwarz CG; Senjem ML; Reid RI; Botha H; Ali F; Ahlskog JE; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
    Parkinsonism Relat Disord; 2019 Sep; 66():56-61. PubMed ID: 31279635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive impairment in progressive supranuclear palsy-Richardson's syndrome is related to white matter damage.
    Caso F; Agosta F; Volonté MA; Ferraro PM; Tiraboschi P; Copetti M; Valsasina P; Falautano M; Comi G; Falini A; Filippi M
    Parkinsonism Relat Disord; 2016 Oct; 31():65-71. PubMed ID: 27453032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diffusion tensor tract-specific analysis of the uncinate fasciculus in patients with progressive supranuclear palsy.
    Kamiya K; Sato N; Ota M; Nakata Y; Ito K; Kimura Y; Murata M; Mori H; Kunimatsu A; Ohtomo K
    J Neuroradiol; 2013 May; 40(2):121-9. PubMed ID: 23428241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy.
    Padovani A; Borroni B; Brambati SM; Agosti C; Broli M; Alonso R; Scifo P; Bellelli G; Alberici A; Gasparotti R; Perani D
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):457-63. PubMed ID: 16306152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. White matter and cortical changes in atypical parkinsonisms: A multimodal quantitative MR study.
    Zanigni S; Evangelisti S; Testa C; Manners DN; Calandra-Buonaura G; Guarino M; Gabellini A; Gramegna LL; Giannini G; Sambati L; Cortelli P; Lodi R; Tonon C
    Parkinsonism Relat Disord; 2017 Jun; 39():44-51. PubMed ID: 28291592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffusion tensor imaging-based multi-fiber tracking reconstructions can regionally differentiate phonetic versus prosodic subtypes of progressive apraxia of speech.
    Gatto RG; Martin PR; Utianski RL; Duffy JR; Clark HM; Botha H; Machulda MM; Josephs KA; Whitwell JL
    Cortex; 2024 Feb; 171():272-286. PubMed ID: 38061209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical correlations of microstructural changes in progressive supranuclear palsy.
    Tessitore A; Giordano A; Caiazzo G; Corbo D; De Micco R; Russo A; Liguori S; Cirillo M; Esposito F; Tedeschi G
    Neurobiol Aging; 2014 Oct; 35(10):2404-10. PubMed ID: 24786632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gray and White Matter Correlates of Dysphagia in Progressive Supranuclear Palsy.
    Clark HM; Tosakulwong N; Weigand SD; Ali F; Botha H; Pham NTT; Schwarz CG; Reid RI; Senjem ML; Jack CR; Lowe VJ; Ahlskog JE; Josephs KA; Whitwell JL
    Mov Disord; 2021 Nov; 36(11):2669-2675. PubMed ID: 34426998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary lateral sclerosis as progressive supranuclear palsy: diagnosis by diffusion tensor imaging.
    Coon EA; Whitwell JL; Jack CR; Josephs KA
    Mov Disord; 2012 Jun; 27(7):903-6. PubMed ID: 22517038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tracking brain damage in progressive supranuclear palsy: a longitudinal MRI study.
    Agosta F; Caso F; Ječmenica-Lukić M; Petrović IN; Valsasina P; Meani A; Copetti M; Kostić VS; Filippi M
    J Neurol Neurosurg Psychiatry; 2018 Jul; 89(7):696-701. PubMed ID: 29348302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sleep disturbances in the speech-language variant of progressive supranuclear palsy.
    Hokelekli FO; Ali F; Carlos AF; Martin PR; Clark HM; Duffy JR; Utianski RL; Botha H; St Louis EK; Whitwell JL; Josephs KA
    Parkinsonism Relat Disord; 2021 Oct; 91():9-12. PubMed ID: 34425331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypic Spectrum of Progressive Supranuclear Palsy: Clinical Study and Apolipoprotein E Effect.
    Nasri A; Sghaier I; Neji A; Gharbi A; Abida Y; Mrabet S; Gargouri A; Djebara MB; Kacem I; Gouider R
    J Mov Disord; 2024 Apr; 17(2):158-170. PubMed ID: 38290492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.